Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

Connection

Search Results to Mark J. Ratain

This is a "connection" page, showing the details of why an item matched the keywords from your search.

                     
                     

One or more keywords matched the following items that are connected to Ratain, Mark J.

Item TypeName
Concept Alcohol Dehydrogenase
Concept Ferredoxin-NADP Reductase
Concept Oxidoreductases, N-Demethylating
Concept Oxidoreductases
Concept Dihydrouracil Dehydrogenase (NADP)
Concept Methylenetetrahydrofolate Reductase (NADPH2)
Concept Aldehyde Oxidase
Concept Aldehyde Dehydrogenase
Academic Article Thymidylate synthase expression and response to neoadjuvant chemotherapy in patients with advanced head and neck cancer.
Academic Article Pharmacogenetics and cancer chemotherapy.
Academic Article Pharmacogenetics in cancer etiology and chemotherapy.
Academic Article Phase I study of eniluracil, a dihydropyrimidine dehydrogenase inactivator, and oral 5-fluorouracil with radiation therapy in patients with recurrent or advanced head and neck cancer.
Academic Article 5-fluorouracil pharmacokinetics: causes for variability and strategies for modulation in cancer chemotherapy.
Academic Article Estimation of the effect of food on the disposition of oral 5-fluorouracil in combination with eniluracil.
Academic Article Pharmacogenetics: a tool for individualizing antineoplastic therapy.
Academic Article Correspondence re: Raida, M. et al., prevalence of a common point mutation in the dihydropyrimidine dehydrogenase (DPD) gene within the 5'-splice donor site of intron 14 in patients with severe 5-fluorouracil (5-FU)-related toxicity compared with controls.
Academic Article Population pharmacokinetic model for irinotecan and two of its metabolites, SN-38 and SN-38 glucuronide.
Academic Article CYP2B6, CYP3A4, and CYP2C19 are responsible for the in vitro N-demethylation of meperidine in human liver microsomes.
Academic Article Phase I study of the ribonucleotide reductase inhibitor 3-aminopyridine-2-carboxaldehyde-thiosemicarbazone (3-AP) in combination with high dose cytarabine in patients with advanced myeloid leukemia.
Academic Article TPMT, UGT1A1 and DPYD: genotyping to ensure safer cancer therapy?
Academic Article Phase I clinical and pharmacologic study of eniluracil plus fluorouracil in patients with advanced cancer.
Academic Article A pharmacogenetic study of aldehyde oxidase I in patients treated with XK469.
Academic Article Clinical evaluation of germline polymorphisms associated with capecitabine toxicity in breast cancer: TBCRC-015.

Search Criteria
  • Oxidoreductases